Caris Life Sciences, Inc. Common Stock (CAI) is a publicly traded Healthcare sector company. As of September 10, 2026, CAI trades at $24.23 with a market cap of $7.01B and a P/E ratio of 14.34. CAI moved +0.82% today. Year to date, CAI is -10.93%; over the trailing twelve months it is -29.22%. Its 52-week range spans $14.19 to $42.50. Analyst consensus is strong buy with an average price target of $26.29. Rallies surfaces CAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CAI insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $24.23 |
| Market Cap | $7.01B |
| P/E Ratio | 14.34 |
| EPS | $1.70 |
| Dividend Yield | 0.30% |
| 52-Week High | $42.50 |
| 52-Week Low | $14.19 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $989.61M |
| Net Income | $105.14M |
| Gross Margin | 0.00% |
8 analysts cover CAI: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.29.